Grants

The Department of Biochemistry & Molecular Medicine at The George Washington University has recently secured a diverse portfolio of grants supporting work in cancer biology, immunotherapy, computational genomics, translational medicine, highlighting the department’s leadership in advancing biomedical discovery.
Active Grants

  • 10/1/2025 – 09/30/2026: Proto-OKN (Mazumder),Biomarker Knowledge graphs, Role: PI of subaward.

  • 09/2024 – 09/2027: U24 1U24OD038423 (Mazumder) ;Enhancing and making Biomarker Knowledge FAIR using contextual CFDE data, Role: PI.

  • 09/27/2024 –07/31/2026: ARPA-H 1AYSAX0000026 (Simonyan, Sedrakyan, Mazumder) ;Federated ecosystem for analytics and standardization technologies, Role: Co-PI.

  • 09/27/2022 – 07/31/2027:NIH 1R24GM146616 (Tiemeyer, Mazumder);Computational and Informatics Resources and Tools for Glycoscience Research;Role: Co-PI.

  • 9/15/2021 – 3/14/2027: NIH 1 OT2 OD032092-01 (Mazumder); (yearly renewal):Harmonization of GlyGen glycoconjugate and glycan array data for integration in CFDE.,Role: PI.

  • 12/12/2024 – 12/01/2029:NIH R01 CA290697 (PI: Seto)NIH/NCI;Targeting histone deacetylase SIRT1 in medulloblastoma.

  • 01/01/2023 – 12/31/2027: NIH R01 CA270149 (PI: Seto);NIH/NCI:Targeting lysine acetyltransferase MOF/KAT8 in lung cancer;.

  • 01/01/2025 – 12/31/2027: ACS INTR-24-1297242-01-DICR (PI: Seto);American Cancer Society;ACS-GW DICR Summer Program Advancing Research on Cancer.

  • 04/24 – 03/29 R01CA279566 (Li/Hu/Curiel, multi-PI award);Adipocyte PD-L1 in the Breast Tumor Microenvironment and Immunotherapy.

  • 03/24 – 03/29 R01 CA288321 (Li/Hu/Zhang, multi-PI award);A Novel Regulator of Antitumor Immunity and Immunotherapy.

  • 07/23 – 07/28 R01 CA282303 (Li/Hu, multi-PI award);T-Cell Specific BRCA1 Function in Antitumor Immunity and Immunotherapy.

  • 03/2023 – 02/2028: Shook (PI) NIH R01AR082417; The role of GPR84 signaling during skin repair.

  • 03/23 – 07/28:Zhu (Contact PI) NIH R01CA275094;Regulation of resistance to CDK4/6 inhibitor in breast cancer

  • 2/2022-1/2027: Zhu (Contact PI) NIH R01CA258357; The role of And-1 in nucleoside excision repair.

  • 01/01/2025 – 12/31/2029: W. Zhu (PI) NIH R01 CA288337;The role of And-1 in R-loop and endocrine resistance in breast cancer.

  • 08/2022 – 07/2027: Wu (PI); NIH R01CA266432; Molecular Function and Mechanism of ARID4B in ERalpha Signaling and Breast Cancer.

  • 08/22 – 08/27: Lee (PI) NIH R37CA270536; 08/22 – 08/27; Understanding lactate catabolism by BACH1 in triple negative breast cancer.

  • 09/2024-08/2026: Horvath(Co-PI)NIH 50109-2-CCLS92184F; Epigenetic mechanisms of HAND pathogenesis

Completed Grants

  • 05/16 – 02/26:Pharmaceutical Company (Mazumder); Vaccine NGS data analysis. Rapid and accurate virus detection from NGS data,Role: PI.

  • 09/24/21-08/31/23:Shook (PI) NIH-NIAMS R21 AR077825, Tracing the origin of regenerative and scarring fibroblasts during wound healing with single-cell technologies.

  • 12/01/2020-11/30/2022: Shook (PI) W.M. Keck Foundation ECNS91477N; RNA Polymerase II Pausing in Cellular Memory.